Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry

Molecular and Cellular Proteomics

Volumn 8, Issue 6, 2009, Pages 1436-1449

  Leth Larsen, Rikke ^a   Lund, Rikke ^a   Hansen, Helle V ^a   Laenkholm, Anne Vibeke ^b   Tarin, David ^c   Jensen, Ole N ^a   Ditzel, Henrik J ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD74 ANTIGEN; CELL PROTEIN; HERMES ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; NUCLEOTIDASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER THERAPY; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLOW UP; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO SELECTION; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RECURRENT DISEASE; TANDEM MASS SPECTROMETRY; TUMOR BIOPSY; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY;

MUS;

EID: 67049095042     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M800061-MCP200     Document Type: Article

References (62)

1. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108
2. Zhang, D. H., Tai, L. K., Wong, L. L., Sethi, S. K., and Koay, E. S. (2005) Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors. Proteomics 5, 1797-1805 (Pubitemid 40686225)
3. Lacroix, M., Toillon, R. A., and Leclercq, G. (2004) Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. Endocr.-Relat. Cancer 11, 497-522
4. Weigelt, B., Peterse, J. L., and van't Veer, L. J. (2005) Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5, 591-602
5. Suzuki, M., Mose, E. S., Montel, V., and Tarin, D. (2006) Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. Am. J. Pathol. 169, 673-681
6. Brabletz, T., Jung, A., Spadema, S., Hlubek, F., and Kirchner, T. (2005) Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749
7. Weigelt, B., Hu, Z., He, X., Uvasy, C., Carey, L. A., Ewend, M. G., Glas, A. M., Perou, C. M., and Van't Veer, L. J. (2005) Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 65, 9155-9158
8. Tu, S. M., Lin, S. H., and Logothetis, C. J. (2002) Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol. 3, 508-513 (Pubitemid 34863672)
9. Suzuki, M., and Tarin, D. (2007) Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications. Mol. Oncol. 1, 172-180
10. Schmidt-Kittler, O., Ragg, T., Daskalakis, A., Granzow, M., Ahr, A., Blankenstein, T. J., Kaufmann, M., Diebold, J., Arnholdt, H., Muller, P., Bischoff, J., Harich, D., Schlimok, G., Riethmuller, G., Eils, R., and Klein, C. A. (2003) From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc. Natl. Acad. Sci. U. S. A. 100, 7737-7742
11. Sun, B., Zhang, S., Zhang, D., Li, Y., Zhao, X., Luo, Y., and Guo, Y. (2008) Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin. Cancer Res. 14, 7050-7059
12. Goodison, S., and Urquidi, V. (2008) Breast tumor metastasis: analysis via proteomic profiling. Expert Rev. Proteomics 5, 457-467 (Pubitemid 351871121)
13. Urquidi, V., Sloan, D., Kawai, K., Agarwal, D., Woodman, A. C., Tarin, D., and Goodison, S. (2002) Contrasting expression of thrombospondin-1 and osteopontin con-elates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 8, 61-74
14. Goodison, S., Kawai, K., Hihara, J., Jiang, P., Yang, M., Urquidi, V., Hoffman, R. M., and Tarin, D. (2003) Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from non-metastatic breast tumors as revealed by labeling with green fluorescent protein. Clin. Cancer Res. 9, 3808-3814
15. Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., and Johnson, M. D. (2007) MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat. 104, 13-19
16. Sellappan, S., Grijalva, R., Zhou, X., Yang, W., Eli, M. B., Mills, G. B., and Yu, D. (2004) Uneage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res. 64, 3479-3485 (Pubitemid 38657921)
17. Montel, V., Huang, T. Y., Mose, E., Pestonjamasp, K., and Tarin, D. (2005) Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am. J. Pathol. 166, 1565-1579
18. Montel, V., Mose, E. S., and Tarin, D. (2006) Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int. J. Cancer 119, 251-263 (Pubitemid 43911887)
19. Schwirzke, M., Evtimova, V., Burtscher, H., Jarsch, M., Tarin, D., and Weidle, U. H. (2001) Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines. Anticancer Res. 21, 1771-1776 (Pubitemid 32728911)
20. Euer, N., Schwirzke, M., Evtimova, V., Burtscher, H., Jarsch, M., Tarin, D., and Weidle, U. H. (2002) Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. Anticancer Res. 22, 733-740 (Pubitemid 34475222)
21. Ong, S. E., Foster, L. J., and Mann, M. (2003) Mass spectrometric-based approaches in quantitative proteomics. Methods 29, 124-130 (Pubitemid 36269199)
22. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
23. Hubbard, A. L., and Ma, A. (1983) Isolation of rat hepatocyte plasma membranes. II. Identification of membrane-associated cytoskeletal proteins. J. Cell Biol. 96, 230-239
24. Matthiesen, R., Bunkenborg, J., Stensballe, A., Jensen, O. N., Welinder, K. G., and Bauw, G. (2004) Database-independent, database-dependent, and extended interpretation of peptide mass spectra in VEMS V2.0. Proteomics 4, 2583-2593 (Pubitemid 39202160)
25. Matthiesen, R., Trelle, M. B., Højrup, P., Bunkenborg, J., and Jensen, O. N. (2005) VEMS 3.0: algorithms and computational tools for tandem mass spectrometry based identification of post-translational modifications in proteins. J. Proteome Res. 4, 2338-2347 (Pubitemid 41814304)
26. Kersey, P. J., Duarte, J., Williams, A., Karavidopoulou, Y., Birney, E., and Apweiler, R. (2004) The International Protein Index: an integrated data-base for proteomics experiments. Proteomics 4, 1985-1988 (Pubitemid 38880363)
27. Reidegeld, K. A., Eisenacher, M., Kohl, M., Chamrad, D., Körting, G., Blüggel, M., Meyer, H. E., and Stephan, C. (2008) An easy-to-use Decoy Database Builder software tool, implementing different decoy strategies for false discovery rate calculation in automated MS/MS protein identifications. Proteomics 8, 1129-1137
28. Hill, A., McFarlane, S., Mulligan, K., Gillespie, H., Draffin, J. E., Trimble, A., Ouhtit, A., Johnston, P. G., Harkin, D. P., McCormick, D., and Waugh, D. J. (2006) Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene 25, 6079-6091 (Pubitemid 44562406)
29. Starlets, D., Gore, Y., Binsky, I., Haran, M., Harpaz, N., Shvidel, L., Becker-Herman, S., Berrebi, A., and Shachar, I. (2006) Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107, 4807-4816 (Pubitemid 43882632)
30. Hunsucker, S. A., Mitchell, B. S., and Spychala, J. (2005) The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol. Ther. 107, 1-30
31. Spychala, J. (2000) Tumor-promoting functions of adenosine. Pharmacol. Ther. 87, 161-173
32. Airas, L., Niemelä, J., Salmi, M., Puurunen, T., Smith, D. J., and Jalkanen, S. (1997) Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J. Cell Biol. 136, 421-431 (Pubitemid 27063091)
33. Spychala, J., Lazarowski, E., Ostapkowicz, A., Ayscue, L. H., Jin, A., and Mitchell, B. S. (2004) Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer. Clin. Cancer Res. 10, 708-717
34. Krüger, K. H., Thompson, L. F., Kaufmann, M., and Möller, P. (1991) Expression of ecto-5′-nucleotidase (CD73) in normal mammary gland and in breast carcinoma. Br. J. Cancer 63, 114-118
35. Ostapkowicz, A., Inai, K., Smith, L., Kreda, S., and Spychala, J. (2006) Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor. Mol. Cancer Ther. 5, 238-245
36. Zhi, X., Chen, S., Zhou, P., Shao, Z., Wang, L., Ou, Z., and Yin, L. (2007) RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin. Exp. Metastasis 24, 439-448
37. Akiyama, S. K., Olden, K., and Yamada, K. M. (1995) Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev. 14, 173-189
38. Taddei, I., Faraldo, M. M., Teulière, J., Deugnier, M. A., Thiery, J. P., and Glukhova, M. A. (2003) Integrins in mammary gland development and differentiation of mammary epithelium. J. Mammary Gland Biol. Neoplasia 8, 383-394
39. Giancotti, F. G., and Ruoslahti, E. (1999) Integrin signaling. Science 285, 1028-1032
40. Newham, P., and Humphries, M. J. (1996) Integrin adhesion receptors: structure, function and implications for biomedicine. Mol. Med. Today 2, 304-313
41. Kikkawa, Y., Sanzen, N., Fujiwara, H., Sonnenberg, A., and Sekiguchi, K. (2000) Integrin binding specificity of laminin-10/11: laminin-10/11 are recognized by α3β1, α6β1 and α6β4 integrins. J. Cell Sci. 113, 869-876
42. Wewer, U. M., Shaw, L. M., Abrechtsen, R., and Mercurio, A. M. (1997) The integrin α6β1 promotes the survival of metastatic human breast carcinoma cells in mice. Am. J. Pathol. 151, 1191-1198
43. Friedrichs, K., Ruiz, P., Franke, F., Gille, I., Terpe, H. J., and Imhof, B. A. (1995) High expression level of α6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 55, 901-906
44. Sloan, E. K., Pouliot, N., Stanley, K. L., Chia, J., Moseley, J. M., Hards, D. K., and Anderson, R. L. (2006) Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res. 8, R20 (Pubitemid 44377911)
45. Altomonte, M., Fonsatti, E., Visintin, A., and Maio, M. (2003) Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach? Oncogene 22, 6564-6569 (Pubitemid 37372336)
46. Sadej, R., Spychala, J., and Skladanowski, A. C. (2006) Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res. 16, 213-222 (Pubitemid 44085095)
47. Goodison, S., Urquidi, V., and Tarin, D. (1999) CD44 cell adhesion molecules. Mol. Pathol. 52, 189-196
48. Tölg, C., Hofmann, M., Herrlich, P., and Ponta, H. (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21, 1225-1229 (Pubitemid 23155620)
49. Afify, A., McNiel, M. A., Braggin, J., Bailey, H., and Paulino, A. F. (2008) Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast. Appl. Immunohistochem. Mol. Morphol. 16, 121-127
50. Lachat, P., Shaw, P., Gebhard, S., van Beizen, N., Chaubert, P., and Bosman, F. T. (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem. Cell Biol. 118, 399-408
51. Bandyopadhyay, S., Pai, S. K., Hirota, S., Hosobe, S., Takano, Y., Saito, K., Piquemal, D., Commes, T., Watabe, M., Gross, S. C., Wang, Y., Ran, S., and Watabe, K. (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23, 5675-5681 (Pubitemid 39093045)
52. Kovacevic, Z., and Richardson, D. R. (2006) The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27, 2355-2366
53. Chua, M. S., Sun, H., Cheung, S. T., Mason, V., Higgins, J., Ross, D. T., Fan, S. T., and So, S. (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod. Pathol. 20, 76-83
54. Cangul, H., Salnikow, K., Yee, H., Zagzag, D., Commes, T., and Costa, M. (2002) Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis. Cell Biol. Toxicol. 18, 87-96
55. Fotovati, A., Fujii, T., Yamaguchi, M., Kage, M., Shirouzu, K., Oie, S., Basaki, Y., Ono, M., Yamana, H., and Kuwano, M. (2006) 17β-Estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Clin. Cancer Res. 12, 3010-3018
56. Bártek, J., Petrek, M., Vojtěsek, B., Bá rtková, J., Kovarík, J., and Rejthar, A. (1987) HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours. Br. J. Cancer 56, 727-733 (Pubitemid 18048341)
57. Claesson, L., Larhammar, D., Rask, L., and Peterson, P. A. (1983) cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. Proc. Natl. Acad. Sci. U. S. A. 80, 7395-7399
58. Strubin, M., Mach, B., and Long, E. O. (1984) The complete sequence of the mRNA for the HLA-DR-associated invariant chain reveals a polypeptide with an unusual transmembrane polarity. EMBO J. 3, 869-872
59. Wraight, C. J., van Endert, P., Moller, P., Lipp, J., Ling, N. R., MacLennan, I. C., Koch, N., and Moldenhauer, G. (1990) Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J. Biol. Chem. 265, 5787-5792
60. Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., Noble, P., Knudson, W., and Bucala, R. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595-606 (Pubitemid 44529040)
61. Meyer-Siegler, K. L., Iczkowski, K. A., Leng, L., Bucala, R., and Vera, P. L. (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J. Immunol. 177, 8730-8739 (Pubitemid 44893839)
62. Burton, J. D., Ely, S., Reddy, P. K., Stein, R., Gold, D. V., Cardillo, T. M., and Goldenberg, D. M. (2004) CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin. Cancer Res. 10, 6606-6611